| Literature DB >> 30149593 |
Ville Mikael Koistinen1, Andreia Bento da Silva2, László Abrankó3, Dorrain Low4, Rocio Garcia Villalba5, Francisco Tomás Barberán6, Rikard Landberg7, Otto Savolainen8, Inmaculada Alvarez-Acero9, Sonia de Pascual-Teresa10, Christof Van Poucke11, Conceição Almeida12, Lucie Petrásková13, Kateřina Valentová14, Stephanie Durand15, Wiesław Wiczkowski16, Dorota Szawara-Nowak17, Raúl González-Domínguez18, Rafael Llorach19, Cristina Andrés-Lacueva20, Anna-Marja Aura21, Tuulikki Seppänen-Laakso22, Kati Hanhineva23, Claudine Manach24, Maria Rosário Bronze25,26,27.
Abstract
Bioactive compounds present in plant-based foods, and their metabolites derived from gut microbiota and endogenous metabolism, represent thousands of chemical structures of potential interest for human nutrition and health. State-of-the-art analytical methodologies, including untargeted metabolomics based on high-resolution mass spectrometry, are required for the profiling of these compounds in complex matrices, including plant food materials and biofluids. The aim of this project was to compare the analytical coverage of untargeted metabolomics methods independently developed and employed in various European platforms. In total, 56 chemical standards representing the most common classes of bioactive compounds spread over a wide chemical space were selected and analyzed by the participating platforms (n = 13) using their preferred untargeted method. The results were used to define analytical criteria for a successful analysis of plant food bioactives. Furthermore, they will serve as a basis for an optimized consensus method.Entities:
Keywords: mass spectrometry; method development; phytochemicals
Year: 2018 PMID: 30149593 PMCID: PMC6161174 DOI: 10.3390/metabo8030046
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1The chemical space (calculated log P as a function of monoisotopic molecular mass, MM) of the reference standards included in the analysis (colored markers), included in the initial list (including grey markers) and included in the proposed analytical coverage quality control mixture (highlighted compounds with bold text).
Platforms that participated in the test with their equipment information and mass spectrometric and chromatographic conditions. ESI = electrospray ionization, EI = electron ionization, * hydrophilic interaction chromatography (HILIC).
| Plat-Form | General Method(s) | HPLC/GC Model | Column (Dimensions, Particle Size, Pore Size) | MS | Ion Source | HPLC Mobile Phase | HPLC Flow | HPLC Gradient (t [min], %B) |
|---|---|---|---|---|---|---|---|---|
| 1 | UHPLC–QTOF | Agilent 1290 | Agilent Poroshell 120 EC-C18 (3 × 100 mm, 2.7 µm, 120 Å) | Agilent 6550 | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 0.4 mL/min | (0, 5), (10, 25), (20, 40), (24, 90), (25, 90), (26, 5), (30, 5) |
| 2 | UHPLC–TOF | Acquity H-class | Acquity UPLC BEH Shield RP18 (2.1 × 150 mm, 1.7 µm, 130 Å) | Synapt G2 S | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 0.35 mL/min | (0, 5), (30, 50), (31, 100), (37, 100), (37.1, 0) |
| 3 | HPLC–QTOF | Thermo U3000 | Acquity HSS T3 (2.1 × 150 mm, 1.8 µm, 100 Å) | Bruker Impact HD2 | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 0.4 mL/min | (0, 0), (2, 0), (15, 100), (22, 100), (22.1, 0), (26, 0) |
| 4 | HPLC–QTOF | Thermo U3000 | Acquity UPLC BEH Shield RP18 (2.1 × 100 mm, 1.7 µm, 130 Å) | Bruker Impact HD2 | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 0.4 mL/min | (0, 0), (2, 0), (7, 10), (22, 95), (22.1, 0), (26, 0) |
| 5 | UHPLC–QTOF | Eksigent nanoLC | Eksigent HALO C18 (0.5 × 50 mm, 2.7 µm, 90 Å) | Sciex Triple-TOF 6600 | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 10 µL/min | (0, 5), (12, 95), (14, 95), (16, 5) |
| 6 | UHPLC–QTOF | Agilent 1260 | Phenomenex Synergi Hydro-RP (2 × 150 mm, 4 µm, 80 Å) | Agilent 6530 | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 0.5 mL/min | (0, 5), (1, 5), (35, 45), (40, 100), (45, 100) |
| 7+ | UHPLC−QTRAP | Agilent 1290 | Luna Omega Polar C18 (2.1 × 100 mm, 1.6 µm, 100 Å) | Sciex 6500 | ESI+ | A: H2O + 0.5% FA, B: ACN + 0.5% FA | 0.5 mL/min | (0, 5), (5, 50), (5.1, 100), (7, 100), (7.1, 5), (9, 5) |
| 7− | UHPLC−QTRAP | Agilent 1290 | Luna Omega Polar C18 (2.1 × 100 mm, 1.6 µm, 100 Å) | Sciex 6500 | ESI− | A: H2O + 0.1% FA + 10 mM NH4COOH, B: ACN | “ | (0, 5), (8, 20), (10, 100), (12, 100), (12.1, 5), (14, 5) |
| 8 | UHPLC–QTOF | Agilent 1290 | Agilent Zorbax Eclipse XDB-C18 (2.1 × 100 mm, 1.8 µm, 80 Å) | Agilent 6540 | ESI+/− | A: H2O + 0.1% FA, B: MeOH + 0.1% FA | 0.4 mL/min | (0, 2), (10, 100), (14.5, 100), (14.51, 2), (16.5, 2) |
| 8H * | UHPLC–QTOF | Agilent 1290 | Waters Aqcuity UPLC BEH Amide (2.1 × 100 mm, 1.7 µm, 130 Å) | Agilent 6540 | ESI+/− | A: 50% ACN + 20 mM NH4COOH, B: 90% ACN + 20 mM NH4COOH; pH = 3 | 0.6 mL/min | (0, 100), (2.5, 100), (10, 0), (10.1, 100), (14, 100) |
| 9 | HPLC–QTOF | Agilent 1200 | Luna C18 (4.6 × 150 mm, 3 µm, 100 Å) | Agilent G6530A | ESI+/− | A: H2O + 0.1% FA, B: ACN + 0.1% FA | 0.5 mL/min | (0, 0), (30, 30), (35, 40), (50, 80), (52, 80), (60, 0), (65, 0) |
| 10 | HPLC–QTOF | AB Sciex MicroLC 200 | Eksigent HALO C18 (0.5 × 100 mm, 2.7 µm, 90 Å) | AB Sciex 5600+ | ESI+/− | A: H2O + 0.9% FA, B: ACN + 0.9% FA | 15 µL/min | (0, 0), (0.5, 0), (4, 95), (4.5, 1), (5, 1) |
| 11 | HPLC–MS | Shimadzu Prominence | Kinetex PFP (4.6 × 150 mm, 5 µm, 100 Å) | Shimadzu LCMS 2020 | ESI+/– | A: H2O + 0.1% TFAB: MeOH | 0.4 mL/min | (0, 40), (25, 80) |
| 12 | GC–MS | Shimadzu 2010 Plus | Restek Rxi-5 ms (15 m, 0.25 mm, 0.25 µm) | Shimadzu TQ-8030 | EI | - | - | - |
| 13 | GC–MS | Agilent 7890A | DB-5 ms (30 m, 0.25 mm, 0.25 µm) | Agilent 5975C MSD | EI | - | - | - |
Figure 2(a) HPLC gradients of the participating untargeted LC–MS platforms including the retention times of trigonelline, hesperetin and ursolic acid plotted against the percentage of solvent B. The numbers of the platforms correspond with Table 1. Platform 7 had separate HPLC methods for positive and negative ionization modes; (b) The same gradients normalized based on a column with dimensions of 2.1 × 100 mm, particle size 1.7 µm, and flow rate 0.4 mL/min.
Figure 3The positive identifications (green), undetected (red) and uncertain identifications (orange) of the chemical standards in different platforms, arranged in a descending order of the number of identifications in all analyses. Quercetin disulfate was not detected in any platform, suggesting that it was not present in the standard mixtures.
Figure 4Separation and identification of three flavonoids, cyanidin, luteolin, and kaempferol, with the same molecular formula of the positive ion (C15H11O6+) in platform 8. The compounds were identified based on their MS/MS spectra, which were compared with reference spectra from publicly available databases [35]. Based on the retention time of cyanidin 3-O-glucoside, also present in the mixture, the feature appearing at RT 1.77 min in platform 7 and 3.5 min in platform 8 was identified as an in-source fragment (cyanidin ion).
Figure 5Separation of isomers from chlorogenic acid (blue), ferulic acid (red), resveratrol (green), and quercetin sulfate (purple; quercetin 3-O- and 4-O-sulfate, from separate chemical standards) in four platforms (10, 8, 3, and 6) using different chromatographic conditions, in ascending order of chromatography runtime. In the platforms, both forms of chlorogenic acid (3-O-caffeoylquinic and 5-O-caffeoylquinic acid) and the cis and trans isomers of ferulic acid and resveratrol, contained in single standards as mixtures, were well separated. However, in platforms 8 and 10, the isomers of quercetin sulfate were not separated due to tailing, and in platform 3, the compounds produced well-separated but weak signals.
Figure 6The elution order of flavonoids (A) and three pairs of closely eluting compounds representing different compound classes (B) in LC–MS platforms using a C18 reversed-phase column. The retention times were normalized based on gallic acid and hesperetin (RTN for hesperetin = 10).